We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1376
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.03M | 0.01% |
44,605
-9,104
| -17% | -$637K |
|
1377
Wabash National
WNC
$512M
| $3.03M | 0.01% |
139,567
+18,822
| +16% | +$392K |
|
1378
AdvanSix
ASIX
$541M
| $3.03M | 0.01% |
71,953
+9,858
| +16% | +$422K |
|
1379
Adtran
ADTN
$689M
| $3.02M | 0.01% |
156,137
+10,739
| +7% | +$238K |
|
1380
RingCentral
RNG
$4.66B
| $3.02M | 0.01% |
62,376
-8,938
| -13% | -$407K |
|
|
RPT
1381
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $3.02M | 0.01% |
204,778
+25,146
| +14% | +$348K |
|
1382
LGI Homes
LGIH
$1.27B
| $3.01M | 0.01% |
40,119
+6,306
| +19% | +$400K |
|
1383
Delek US
DK
$4.16B
| $3.01M | 0.01% |
86,107
-12,134
| -12% | -$358K |
|
|
SYKE
1384
DELISTED
SYKES Enterprises Inc
SYKE
| $3M | 0.01% |
95,321
+13,189
| +16% | +$398K |
|
|
TVTY
1385
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $2.99M | 0.01% |
81,825
+10,700
| +15% | +$406K |
|
|
TWOU
1386
DELISTED
2U Inc
TWOU
| $2.99M | 0.01% |
1,544
-161
| -9% | -$302K |
|
1387
MiMedx Group
MDXG
$602M
| $2.98M | 0.01% |
236,574
+31,987
| +16% | +$390K |
|
1388
Safety Insurance
SAFT
$1.52B
| $2.98M | 0.01% |
37,093
+5,108
| +16% | +$413K |
|
1389
Golar LNG
GLNG
$5B
| $2.98M | 0.01% |
99,955
-16,668
| -14% | -$401K |
|
1390
Generac Holdings
GNRC
$11.6B
| $2.98M | 0.01% |
60,084
-10,228
| -15% | -$508K |
|
1391
Matsons
MATX
$6.13B
| $2.97M | 0.01% |
99,592
+13,276
| +15% | +$375K |
|
|
QTS
1392
DELISTED
QTS REALTY TRUST, INC.
QTS
| $2.97M | 0.01% |
54,879
-7,021
| -11% | -$391K |
|
1393
iShares Russell 2000 ETF
IWM
$79.8B
| $2.96M | 0.01% |
19,451
+5,516
| +40% | +$829K |
|
|
EPAY
1394
DELISTED
Bottomline Technologies Inc
EPAY
| $2.96M | 0.01% |
85,406
+10,436
| +14% | +$350K |
|
1395
Mativ Holdings
MATV
$481M
| $2.96M | 0.01% |
65,264
+1,228
| +2% | +$53.3K |
|
|
USCR
1396
DELISTED
U S Concrete, Inc.
USCR
| $2.95M | 0.01% |
35,293
+5,899
| +20% | +$464K |
|
|
IPXL
1397
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.95M | 0.01% |
177,081
+21,775
| +14% | +$399K |
|
1398
8x8 Inc
EGHT
$269M
| $2.91M | 0.01% |
206,638
+30,333
| +17% | +$419K |
|
1399
Check Point Software Technologies
CHKP
$13B
| $2.91M | 0.01% |
28,095
+100
| +0.4% | +$10.9K |
|
1400
Hilton Grand Vacations
HGV
$3.59B
| $2.91M | 0.01% |
69,284
+2,346
| +4% | +$95.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.